SCHEMBL2914542

SCHEMBL2914542

CC(=O)c1ccc(Cl)c(CN)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.49
ALDH1A1 P00352 4/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ADRB2 P07550 1/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
HTT P42858 1/20 0.44
POLB P06746 2/20 0.42
HTR1A P08908 1/20 0.42
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.41
PNMT P11086 1/20 0.41
CREBBP Q92793 1/20 0.40
ATM Q13315 1/20 0.40
PRKCI P41743 1/20 0.40
MAPK1 P28482 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13361795 0.85 PKM (0.52) PKMALDH1A1GAAMAPTL3MBTL1
SCHEMBL27722152 0.83 SLC6A4 (0.50) POLBHTR1AHTR1DHTR1BKMT2A
SCHEMBL7450888 0.83 TSHR (0.59) ALDH1A1GAAMAPTL3MBTL1POLB
SCHEMBL19575714 0.81 PNMT (0.41) ALDH1A1GAAMAPTL3MBTL1MAOA
Hydrochloric Acid SCHEMBL7352172 0.81 TSHR (0.57) ALDH1A1MAPTL3MBTL1KMT2AMEN1
SCHEMBL9411180 0.80 PKM (0.47) PKMALDH1A1GAAMAPTL3MBTL1
SCHEMBL10743832 0.79 PKM (0.70) PKMALDH1A1HTTPOLBHTR1A
SCHEMBL15672467 0.79 PKM (0.50) PKMALDH1A1GAAMAPTL3MBTL1
SCHEMBL27951772 0.78 ADRB2 (0.43) PKMALDH1A1GAAMAPTL3MBTL1
Hydrochloric Acid SCHEMBL10738531 0.78 PKM (0.68) PKMALDH1A1HTTPOLBHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2719684-A1 METHOD OF MANUFACTURING BENZYLAMINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2014-04-16 EP disclosed
EP-1586552-B1 PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE IHARA CHEMICAL IND CO (JP) 2010-08-25 EP disclosed
US-7326813-B2 Process for producing benzylamine derivative IHARA CHEMICAL INDUSTRY (JP) 2008-02-05 US disclosed
US-20060155141-A1 Process for producing benzylamine derivative ITO AKINORI 2006-07-13 US disclosed
EP-1586552-A1 PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 2005-10-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060155141-A1 Process for producing benzylamine derivative BRD7, BRD1, BRD2 PKM 4237/4885ALDH1A1 2660/4885GAA 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.